| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abrdn Life Sciences Investors (HQL) has 2 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. HQL is classified in the Capital Markets industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.84M | $51.62M | - | |
| Dir | 7.9K | $144.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2020 | Omstead Daniel R63 | President | Buy | 5,950 | $17.75 | $105,605.95 | +5.0% | |
| Sep 22, 2020 | Bailey Jeffrey Allen | Director | Buy | 580 | $17.28 | $10,022.40 | New | |
| May 21, 2020 | Omstead Daniel R63 | President | Buy | 5,950 | $17.74 | $105,556.57 | +5.5% | |
| Mar 17, 2020 | Omstead Daniel R63 | President | Buy | 8,300 | $13.27 | $110,106.97 | +8.5% | |
| Jan 25, 2018 | Kent Thomas M | Director | Buy | 1,300 | $21.04 | $27,347.97 | New | |
| Jun 29, 2015 | Stebbins Lucinda H | Director | Buy | 1,000 | $28.17 | $28,170.00 | +20.1% |